Atlas Trials

Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects

Clinical trial NCT03929016 · COMPLETED

Trial details

NCT number
NCT03929016
Sponsor
Drugs for Neglected Diseases
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Visceral LeishmaniasisCutaneous Leishmaniases
Start date
2019-04-04
Primary completion
2019-12-06
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.